Sydney (SYDNEY.NDX)

Close: 7 447.60 (+15.40), Nov 25, 2022
Weak Positive

Automatic technical analysis. Medium term, Nov 25, 2022

Sydney shows weak development in a falling trend channel in the medium long term. Falling trends indicate that the market experiences negative development and falling buy interest among investors. The index has given a positive signal from the double bottom formation by a break up through the resistance at 7381. Further rise to 8120 or more is signaled. The index is between support at points 7370 and resistance at points 7520. A definitive break through of one of these levels predicts the new direction. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The RSI curve shows a rising trend, which is an early signal of a possible trend reversal upwards for the price as well. The index is overall assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.70%0.00+0.21%
5 days0.002.24%0.00+1.26%
22 days0.005.73%0.00+6.32%
66 days0.0010.13%0.00+2.83%

More analyses of Sydney

chart Sydney (SYDNEY) Candlesticks 22 Days
Candlesticks
chart Sydney (SYDNEY) Short term
Short term: Positive
chart Sydney (SYDNEY) Medium term
Medium term: Weak Positive
chart Sydney (SYDNEY) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+